• Product nameAnti-GALNT14 antibody
    See all GALNT14 primary antibodies
  • Description
    Rabbit polyclonal to GALNT14
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat, Horse, Chicken, Guinea pig, Cow, Cat, Dog, Zebrafish
  • Immunogen

    Synthetic peptide corresponding to a region within internal sequence amino acids 324-373 (EIVPCSRVGH VFRKKHPYVF PDGNANTYIK NTKRTAEVWM DEYKQYYYAA) of Human GALNT14 (NP_078848).

  • Positive control
    • OVCAR-3 cell lysate.



Our Abpromise guarantee covers the use of ab86526 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 1 µg/ml. Predicted molecular weight: 64 kDa. Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.


  • FunctionCatalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. Displays activity toward mucin-derived peptide substrates such as Muc2, Muc5AC, Muc7, and Muc13 (-58). May be involved in O-glycosylation in kidney.
  • Tissue specificityHighly expressed in fetal and adult kidney. Widely expressed at low level. Weakly expressed in whole brain, cerebellum, thymus, lung, mammary gland, liver, stomach, small intestine, colon, pancreas, spleen, bladder, uterus, placenta, testis, ovary, skeletal muscle, leukocyte, B-cell, bone marrow, fetal brain, fetal thymus, fetal lung, fetal liver, fetal small intestine, fetal spleen, fetal skeletal and fetus.
  • PathwayProtein modification; protein glycosylation.
  • Sequence similaritiesBelongs to the glycosyltransferase 2 family. GalNAc-T subfamily.
    Contains 1 ricin B-type lectin domain.
  • DomainThere are two conserved domains in the glycosyltransferase region: the N-terminal domain (domain A, also called GT1 motif), which is probably involved in manganese coordination and substrate binding and the C-terminal domain (domain B, also called Gal/GalNAc-T motif), which is probably involved in catalytic reaction and UDP-Gal binding.
    The ricin B-type lectin domain binds to GalNAc and contributes to the glycopeptide specificity.
  • Cellular localizationGolgi apparatus membrane.
  • Information by UniProt
  • Database links
  • Alternative names
    • GalNAc T14 antibody
    • GalNAc-T14 antibody
    • Galnt14 antibody
    • GLT14_HUMAN antibody
    • Polypeptide GalNAc transferase 14 antibody
    • Polypeptide N acetylgalactosaminyltransferase 14 antibody
    • Polypeptide N-acetylgalactosaminyltransferase 14 antibody
    • pp GaNTase 14 antibody
    • pp-GaNTase 14 antibody
    • Protein UDP acetylgalactosaminyltransferase 14 antibody
    • Protein-UDP acetylgalactosaminyltransferase 14 antibody
    • UDP GalNAc:polypeptide N acetylgalactosaminyltransferase 14 antibody
    • UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 14 antibody
    see all

Anti-GALNT14 antibody images

  • Anti-GALNT14 antibody (ab86526) at 1 µg/ml (in 5% skim milk / PBS buffer) + OVCAR-3 cell lysate at 10 µg

    HRP conjugated anti-Rabbit IgG at 1/50000 dilution

    Predicted band size : 64 kDa
    Observed band size : 74 kDa (why is the actual band size different from the predicted?)
    Additional bands at : 28 kDa. We are unsure as to the identity of these extra bands.

References for Anti-GALNT14 antibody (ab86526)

ab86526 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab86526.
Please use the links above to contact us or submit feedback about this product.